In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-20
IMMUImmunomedics IncMarkison Brian ADirS - Sale+OE$11.89-8,39090,788-8%-$99,724
D
2017-11-17
NEOGNeogen CorpBradley EdwardVPS - Sale+OE$80.32-17,82421,512-45%-$1,431,624
D
2017-11-16
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$54.35-7,00010,392-40%-$380,450
2017-11-17
LNTHLantheus Holdings, Inc.Healey Timothy GSVP, CommercialS - Sale$21.51-11,31466,362-15%-$243,400
DM
2017-11-14
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$150.52-54,0001,144,573-5%-$8,128,136
D
2017-11-14
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$81.29-18,000873,005-2%-$1,463,287
2017-11-15
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$1.46+68561,963+1%+$1,000
2017-11-14
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$21.63-11,917152,301-7%-$257,787
M
2017-11-14
IMMUImmunomedics IncVenbio Select Advisor LLCSee Remarks, 10%P - Purchase$10.47+1,325,00031,953,922+4%+$13,868,250
M
2017-11-14
IMMUImmunomedics IncAghazadeh BehzadSee Remarks, 10%P - Purchase$10.47+1,325,00031,953,922+4%+$13,868,250
D
2017-11-13
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$81.45-26,000872,430-3%-$2,117,700
2017-11-13
MYGNMyriad Genetics IncFord AlexanderPres, MGLS - Sale$31.64-3,03176,769-4%-$95,897
2017-11-09
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale$38.91-7,9657,642-51%-$309,907
D
2017-11-06
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale+OE$39.50-7,5653,718-67%-$298,818
DM
2017-11-03
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$151.32-54,0001,144,573-5%-$8,171,447
D
2017-11-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale+OE$13.35-3,00015,000-17%-$40,050
D
2017-10-31
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$80.26-4,00010,103-28%-$321,040
DM
2017-10-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$41.55-36,000284,493-11%-$1,495,752
DM
2017-10-16
QTNTQuotient LtdCowan D J Paul ESee RemarksS - Sale+OE$4.64-100,0003,185,175-3%-$463,941
2017-10-16
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$1.44+69461,278+1%+$999
2017-10-13
LNTHLantheus Holdings, Inc.Crowley John W.CFOS - Sale$18.41-6,755144,906-4%-$124,366
2017-10-09
NEOGNeogen CorpBradley EdwardVPS - Sale$78.60-20,00021,512-48%-$1,572,054
D
2017-10-04
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$78.32-14,513871,430-2%-$1,136,645
D
2017-10-04
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$78.10-5,40128,185-16%-$421,833
D
2017-10-04
NEOGNeogen CorpBradley EdwardVPS - Sale+OE$78.60-5,40141,512-12%-$424,518
D
2017-10-04
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$78.52-2,25010,103-18%-$176,676
D
2017-10-02
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$16.78-55,000461,668-11%-$922,933
D
2017-09-29
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$77.06-10,000869,212-1%-$770,565
DM
2017-09-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$42.91-36,000284,493-11%-$1,544,880
2017-09-28
NEOGNeogen CorpBradley EdwardVPS - Sale$76.79-20,00041,512-33%-$1,535,830
2017-09-27
NEOGNeogen CorpMorrical Terri AVPS - Sale$75.01-11,39828,185-29%-$854,964
D
2017-09-25
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$73.54-2,77210,103-22%-$203,853
D
2017-09-20
NEOGNeogen CorpBradley EdwardVPS - Sale+OE$71.28-38,87661,512-39%-$2,771,128
DM
2017-09-15
QTNTQuotient LtdCowan D J Paul ESee RemarksS - Sale+OE$4.41-100,0003,285,175-3%-$440,654
2017-09-19
VNRXVolitionrx LtdVanston David CecilCFOP - Purchase$2.84+2,7502,750New+$7,810
2017-09-15
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$1.39+71960,584+1%+$999
2017-09-13
NTLAIntellia Therapeutics, Inc.Caribou Biosciences, Inc.10%S - Sale$0.00-1,048,8464,545,000-19%-$0
D
2017-09-11
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale+OE$16.45-20,000164,218-11%-$328,978
M
2017-09-08
NEOGNeogen CorpBradley EdwardVPS - Sale$70.06-13,62861,512-18%-$954,785
2017-09-07
LNTHLantheus Holdings, Inc.Burgstahler David FDirS - Sale$16.56-102,95853,079-66%-$1,704,984
2017-09-05
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$16.69-18,00087,078-17%-$300,476
M
2017-09-05
NEOGNeogen CorpBradley EdwardVPS - Sale$70.05-6,37275,140-8%-$446,371
M
2017-09-01
LNTHLantheus Holdings, Inc.Burgstahler David FDirS - Sale$16.95-78,83367,494-54%-$1,336,384
M
2017-08-31
IMMUImmunomedics IncGoldenberg Cynthia LDirS - Sale$12.64-20,0005,906,2330%-$252,750
M
2017-08-31
IMMUImmunomedics IncGoldenberg David MSee RemarksS - Sale$12.64-20,0005,806,0670%-$252,750
D
2017-09-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale+OE$15.82-3,00015,000-17%-$47,460
D
2017-09-01
MYGNMyriad Genetics IncHenderson John TDirS - Sale+OE$30.30-30,00042,824-41%-$909,040
M
2017-08-29
LNTHLantheus Holdings, Inc.Burgstahler David FDirS - Sale$17.25-230,68580,073-74%-$3,979,680
DM
2017-08-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$34.44-36,000284,493-11%-$1,239,984
D
2017-08-28
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$150.79-13,0001,132,034-1%-$1,960,264
M
2017-08-24
IMMUImmunomedics IncGoldenberg David MSee RemarksS - Sale$10.72-40,0003,415,578-1%-$428,946
M
2017-08-24
IMMUImmunomedics IncGoldenberg Cynthia LDirS - Sale$10.72-40,0005,926,233-1%-$428,946
M
2017-08-24
LNTHLantheus Holdings, Inc.Burgstahler David FDirS - Sale$17.01-91,166112,289-45%-$1,550,885
M
2017-08-22
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale$153.29-5,15614,696-26%-$790,342
2017-08-21
NEOGNeogen CorpBradley EdwardVPS - Sale$65.08-5,00081,512-6%-$325,407
2017-08-24
VIVOMeridian Bioscience IncKraeutler John ACOB, CEOP - Purchase$13.67+7,000345,991+2%+$95,694
A
2017-08-15
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale$16.14-9,73992,905-9%-$157,171
2017-08-23
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$1.30+76859,865+1%+$998
M
2017-08-21
IMMUImmunomedics IncGoldenberg David MSee RemarksS - Sale$9.24-40,0005,866,067-1%-$369,426
M
2017-08-21
IMMUImmunomedics IncGoldenberg Cynthia LDirS - Sale$9.24-40,0005,966,233-1%-$369,426
DM
2017-08-18
QTNTQuotient LtdCowan D J Paul ESee RemarksS - Sale+OE$3.52-45,5403,385,175-1%-$160,296
DM
2017-08-15
QTNTQuotient LtdCowan D J Paul ESee RemarksS - Sale+OE$4.06-54,4603,430,715-2%-$221,111
2017-08-16
VNRXVolitionrx LtdRootsaert Rodney GerardSecretaryP - Purchase$2.77+3,6301,012,5460%+$10,055
2017-08-16
VNRXVolitionrx LtdReynolds Cameron JohnPres, CEOP - Purchase$2.77+3,6302,156,4670%+$10,055
DM
2017-08-14
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$155.00-58,0001,129,034-5%-$8,990,173
M
2017-08-14
LNTHLantheus Holdings, Inc.Avista Capital Partners Gp, LLC10%S - Sale$17.27-140,846240,092-37%-$2,432,665
M
2017-08-14
LNTHLantheus Holdings, Inc.Burgstahler David FDirS - Sale$17.27-140,846254,902-36%-$2,432,665
2017-08-15
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale$16.14-9,73992,905-9%-$157,171
D
2017-08-09
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$154.54-17,0001,123,034-1%-$2,627,183
D
2017-08-08
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$68.68-4,00010,103-28%-$274,736
D
2017-08-08
NEOGNeogen CorpGreen Ronald DDirS - Sale+OE$68.49-4,3330-100%-$296,772
D
2017-08-08
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$155.22-18,0001,120,034-2%-$2,793,960
2017-08-07
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale$17.70-22,371102,644-18%-$395,971
2017-08-03
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$151.76+2,0003,344+149%+$303,517
M
2017-08-02
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.73+10,0003,181,6500%+$37,300
D
2017-07-28
QDELQuidel Corp /de/Steward Randall JCFOS - Sale+OE$34.09-94,21519,907-83%-$3,211,931
2017-07-28
QDELQuidel Corp /de/Abney Michael Donald Jr.SVP - DistributionS - Sale$33.83-1,173866-58%-$39,679
M
2017-07-28
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.72+15,0003,221,2000%+$55,800
DM
2017-07-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$33.83-36,000284,493-11%-$1,217,820
2017-07-27
NEOGNeogen CorpPapesh G BruceDirS - Sale$64.51-6,75019,696-26%-$435,443
2017-07-27
NEOGNeogen CorpTobin James PDirP - Purchase$64.64+5003,200+19%+$32,320
2017-07-27
ICCCImmucell Corp /de/Pessin Norman HSee Explanation of ResponsesP - Purchase$5.25+170,000650,000+35%+$892,500
2017-07-27
ICCCImmucell Corp /de/Pessin Brian L.See Explanation of ResponsesP - Purchase$5.25+30,00070,000+75%+$157,500
D
2017-07-20
QTNTQuotient LtdCowan D J Paul ESee Remarks, 10%S - Sale+OE$6.11-9,4203,485,1750%-$57,556
2017-07-19
NEOGNeogen CorpBradley EdwardVPS - Sale$66.33-5,00086,512-5%-$331,657
DM
2017-07-17
QTNTQuotient LtdCowan D J Paul ESee Remarks, 10%S - Sale+OE$6.39-90,5803,494,595-3%-$578,612
2017-07-14
ABIOArca Biopharma, Inc.Conway Robert EChairman of the BoardP - Purchase$2.49+10,00035,000+40%+$24,900
2017-07-12
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$18.05-10,000592,468-2%-$180,500
M
2017-07-07
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$16.24-150,0003,579,788-4%-$2,435,440
M
2017-07-07
NTLAIntellia Therapeutics, Inc.Atlas Venture Fund Ix, L.P.10%S - Sale$16.24-150,0003,579,788-4%-$2,435,440
D
2017-07-06
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$15.94-27,168461,668-6%-$433,006
M
2017-07-05
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$4.00+11,5003,503,5000%+$46,030
D
2017-07-05
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$16.58-32,832461,668-7%-$544,427
2017-06-29
NAVBNavidea Biopharmaceuticals, Inc.Regan William J.SVP, CCOP - Purchase$0.53+20,000172,977+13%+$10,586
DM
2017-06-28
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$27.30-36,000284,493-11%-$982,920
M
2017-06-27
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$4.09+8,5003,343,3500%+$34,795
D
2017-06-28
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$16.06-30,000461,668-6%-$481,797
M
2017-06-22
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.80+15,0003,780,8000%+$56,975
2017-06-20
LNTHLantheus Holdings, Inc.Avista Capital Partners Gp, LLC10%S - Sale$14.87-3,000,0001,762,208-63%-$44,610,000
2017-06-20
LNTHLantheus Holdings, Inc.Burgstahler David FDir, 10%S - Sale$14.87-3,000,0001,762,208-63%-$44,610,000

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top